Search Results

There are 9997 results for: content related to: Adenosine A 2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

  1. You have full text access to this OnlineOpen article
    Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects

    The Journal of Clinical Pharmacology

    Mayumi Mukai, Tatsuo Uchimura, Xiaoping Zhang, Douglas Greene, Maria Vergeire and Marc Cantillon

    Version of Record online : 7 SEP 2017, DOI: 10.1002/jcph.1003

  2. Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1468–1481, Dr William Knebel, Dr Niranjan Rao, Dr T. Uchimura, Dr Akihisa Mori, Ms Jeannine Fisher, Dr Marc R. Gastonguay and Dr Philip Chaikin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011420566

  3. Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study

    Movement Disorders

    Volume 25, Issue 10, 30 July 2010, Pages: 1437–1443, Yoshikuni Mizuno, Kazuko Hasegawa, Tomoyoshi Kondo, Sadako Kuno, Mitsutoshi Yamamoto and The Japanese Istradefylline Study Group

    Version of Record online : 13 APR 2010, DOI: 10.1002/mds.23107

  4. Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease

    The Journal of Clinical Pharmacology

    Volume 51, Issue 1, January 2011, Pages: 40–52, Dr William Knebel, Dr Niranjan Rao, Dr Tatsuo Uchimura, Dr Akihisa Mori, Dr Jeannine Fisher, Dr Marc R. Gastonguay and Dr Philip Chaikin

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010363809

  5. A Study of the Pharmacokinetic Interaction of Istradefylline, a Novel Therapeutic for Parkinson's Disease, and Atorvastatin

    The Journal of Clinical Pharmacology

    Volume 48, Issue 9, September 2008, Pages: 1092–1098, Dr N. Rao, Dr B. Dvorchik, Dr N. Sussman, Ms H. Wang, Mr K. Yamamoto, Dr A. Mori, Mr T. Uchimura and Dr P. Chaikin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008320924

  6. You have full text access to this OnlineOpen article
    Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1138–1141, Yoshikuni Mizuno, Tomoyoshi Kondo and the Japanese Istradefylline Study Group

    Version of Record online : 11 MAR 2013, DOI: 10.1002/mds.25418

  7. Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations

    Movement Disorders

    Volume 23, Issue 15, 15 November 2008, Pages: 2177–2185, Robert A. Hauser, Lisa M. Shulman, Joel M. Trugman, John W. Roberts, Akihisa Mori, Rocco Ballerini and Neil M. Sussman

    Version of Record online : 2 OCT 2008, DOI: 10.1002/mds.22095

  8. Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease

    Movement Disorders Clinical Practice

    Volume 2, Issue 4, December 2015, Pages: 331–340, Emmanuelle Pourcher and Philippe Huot

    Version of Record online : 25 JUL 2015, DOI: 10.1002/mdc3.12187

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 3, Issue 3, 320, Version of Record online: 1 JUN 2016

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  10. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  11. Author's Response

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Page: 784, Niranjan Rao

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010377504

  12. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  13. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  14. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  15. Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?

    Annals of Neurology

    Volume 63, Issue 3, March 2008, Pages: 267–269, Joseph Jankovic

    Version of Record online : 26 MAR 2008, DOI: 10.1002/ana.21348

  16. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  17. American Society for Clinical Pharmacology and Therapeutics

    Clinical Pharmacology & Therapeutics

    Volume 99, Issue S1, February 2016, Pages: S5–S107,

    Version of Record online : 24 JAN 2016, DOI: 10.1002/cpt.310

  18. Adenosine A2A receptor antagonist istradefylline for levodopa-induced complications in Parkinson's disease

    Intervention Protocol

    The Cochrane Library

    Yousheng Xiao, Lu Gan and Jin Wang

    Published Online : 14 MAR 2012, DOI: 10.1002/14651858.CD009709

  19. History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

    Medicinal Research Reviews

    Volume 35, Issue 4, July 2015, Pages: 790–848, Delia Preti, Pier Giovanni Baraldi, Allan R. Moorman, Pier Andrea Borea and Katia Varani

    Version of Record online : 27 MAR 2015, DOI: 10.1002/med.21344

  20. An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats

    Fundamental & Clinical Pharmacology

    Volume 25, Issue 5, October 2011, Pages: 608–618, Brigitte Spinnewyn, Christelle Charnet, Sylvie Cornet, Véronique Roubert, Pierre-Etienne Chabrier and Michel Auguet

    Version of Record online : 16 NOV 2010, DOI: 10.1111/j.1472-8206.2010.00883.x